Basaglar 100 IU/mL insulin glargine pens 3 mL pack of 5 (refrigerated)

Product description: contains Basaglar with insulin glargine. this insulin modified, very similar to human insulin. Basaglar used for treatment of diabetes in adults and adolescents and children aged two years and above. diabetes is a disease in which your body does not produce enough insulin to control its blood sugar level. insulin glargine has a long and steady effect in lowering blood sugar levels. Usage instructions: a new needle must be attached before each use. only compatible needles with use should be used. a safety test must be performed before each injection. look at the cartridge before using the pen. do not use BASAGLAR KwikPen if particles are observed in it. only use BASAGLAR KwikPen if the solution is clear, colorless, and water-like. do not shake or mix it before use. to prevent the possibility of disease transmission, each pen should be used by only one patient. ensure that insulin is not contaminated with alcohol, disinfectants, or other substances. Basaglar is injected under the skin. do not inject Basaglar into a vein as this will change its effect and may cause hypoglycemia. your doctor will show you which area of the skin to inject Basaglar. with each injection, change the injection site within a specific area of the skin you use. Basaglar is given subcutaneously by injection into the wall of the abdomen, thigh, upper arm, deltoid area, or gluteal area. injection sites should always be rotated within the same area to reduce the risk of lipohypertrophy and amyloidosis. always use a new pen if blood sugar control worsens unexpectedly. if you think you may have a problem with BASAGLAR KwikPen, consult your doctor, pharmacist, or nurse. empty pens should not be refilled and must be disposed of properly. do not use BASAGLAR KwikPen if it is damaged or not working properly, it should be disposed of. a new KwikPen must be used. Warnings and precautions: talk to your doctor, pharmacist, or nurse before using Basaglar. closely follow instructions for weight measurement, monitoring (blood and urine tests), diet, and physical activity (exercise and workouts) as discussed with your doctor. skin changes at the injection site: rotate the injection site to prevent skin changes such as lumps under the skin. insulin may not work well if injected into a lumped area (see how to use Basaglar). contact your doctor if you are currently injecting into a lumped area before starting to inject into a different area. your doctor may advise you to monitor blood sugar more closely and adjust insulin or other anti-diabetic medication doses. Travel: before traveling, consult your doctor. you may need to discuss: availability of insulin in the country you are visiting. insulin supplies, etc. proper storage of insulin during travel. timing of meals and insulin administration during travel. potential effects of switching to different time zones. new health risks in the countries to be visited. what to do in emergencies when you feel unwell or sick. Diseases and injuries: in the following cases, managing your diabetes may require extra care (e.g., adjusting insulin doses and blood and urine tests): if you are ill or have a serious injury, blood sugar levels may rise (hyperglycemia). if you do not eat enough, blood sugar levels may become very low (hypoglycemia). in most cases, you will need a doctor. be sure to contact the doctor early. if you have type 1 diabetes (insulin-dependent diabetes), do not stop taking insulin and continue to do so to get enough carbohydrates. always inform those who care for you or treat you that insulin is required. insulin therapy can cause the body to produce insulin antibodies (substances that work against insulin). however, this rarely requires changing the insulin dose. some patients with long-term type 2 diabetes and previous heart disease or stroke treated with pioglitazone and insulin experience heart failure. inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath, rapid weight gain, or localized swelling (edema). Components: the active substance is insulin glargine. each milliliter of solution contains 100 units of active insulin glargine (equivalent to 3.64 mg). other components are: zinc oxide, metacresol, glycerin, sodium hydroxide (see section 2). Product details: product type: pre-filled insulin pen. brand: Basaglar. product model: pre-filled injection pen.